The 22nd meeting of the EURORDIS Round Table of Companies recently took place in Brussels on the occasion of Rare Disease Day 2015 and focused on the theme ‘Rare Diseases: Going Global’.
This EURORDIS corporate-membership group meets twice a year to discuss topics relating to the development of and access to rare disease treatments. It brings together pharmaceutical, biotech and service companies whose work has an impact on people living with a rare disease and that share a common interest in rare diseases and orphan medicines development
Rare diseases are not yet recognised as an international public health priority. EURORDIS wants to change this in the next 5 to 10 years.